The limits of the cellular capacity to mediate an estrogen response
- PMID: 1569962
- DOI: 10.1210/mend.6.2.1569962
The limits of the cellular capacity to mediate an estrogen response
Abstract
While steroid response is generally restricted by the availability of steroid receptors, the theoretical limits of the response are not known. We have constructed a series of cell lines that stably express the estrogen receptor (ER) at levels up to 5,000,000 ERs per cell and employed these cells to explore the limits of the estrogen response. Several reporter genes with estrogen response elements upstream of the herpes thymidine kinase promoter showed hyperbolic saturation kinetics with increasing ER. Maximum response was 10 times that seen in cell lines with receptor titers comparable to physiological levels. Half-maximal responses required 500,000 receptors per cell, and cells with 5,000,000 ERs showed greater than 90% maximum induction. Estradiol dose-response studies indicated that the receptors are limiting below 500,000 ERs per cell, but at higher ER titers there are spare receptors. In contrast to most reporters, the widely used reporter pA2-CAT, which has 200 base pairs of Xenopus vitellogenin DNA between the response element and the promoter, showed squelching at ER levels beyond 500,000 per cell. Cell lines that expressed ER above this level activated pA2-CAT with a distorted hormone dependence, where saturating ligand concentrations were inhibitory. All reporters displayed squelching when the ER was provided by transient transfection at a level that we judge is 20,000,000 per cell by extrapolation from the behavior of stable cell lines. These findings suggest that saturation of the cellular capacity to mediate an estrogen response and ER-dependent squelching occur at receptor titers well above those encountered in nature. If current models of steroid hormone action are correct, the findings also imply that estrogen response elements are occupied to very small extents under normal conditions.
Similar articles
-
Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor.Endocrinology. 1992 May;130(5):2617-24. doi: 10.1210/endo.130.5.1572285. Endocrinology. 1992. PMID: 1572285
-
Overexpression of estrogen receptor in HTB 96 human osteosarcoma cells results in estrogen-induced growth inhibition and receptor cross talk.J Bone Miner Res. 1994 Aug;9(8):1251-8. doi: 10.1002/jbmr.5650090815. J Bone Miner Res. 1994. PMID: 7976507
-
An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.Mol Endocrinol. 2000 May;14(5):634-49. doi: 10.1210/mend.14.5.0460. Mol Endocrinol. 2000. PMID: 10809228
-
The role of ligand in estrogen receptor regulation of gene expression.Mol Cell Endocrinol. 1991 Jul;78(3):C103-8. doi: 10.1016/0303-7207(91)90114-8. Mol Cell Endocrinol. 1991. PMID: 1778298 Review.
-
Understanding the interaction of estrogenic ligands with estrogen receptors: a survey of the functional and binding kinetic studies.J Environ Sci Health C Toxicol Carcinog. 2020;38(2):142-168. doi: 10.1080/26896583.2020.1761204. Epub 2020 May 7. J Environ Sci Health C Toxicol Carcinog. 2020. PMID: 32500833 Review.
Cited by
-
Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.Horm Cancer. 2020 Aug;11(3-4):129-147. doi: 10.1007/s12672-020-00388-0. Epub 2020 Jun 26. Horm Cancer. 2020. PMID: 32592004 Free PMC article. Review.
-
Expression of estrogen receptor-alpha and -beta in anterior vaginal walls of genuine stress incontinent women.Int Urogynecol J Pelvic Floor Dysfunct. 2003 Oct;14(4):276-81; discussion 281. doi: 10.1007/s00192-003-1042-7. Epub 2003 Aug 2. Int Urogynecol J Pelvic Floor Dysfunct. 2003. PMID: 14530841
-
Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis.Multidiscip Respir Med. 2011 Oct 31;6(5):313-7. doi: 10.1186/2049-6958-6-5-313. Multidiscip Respir Med. 2011. PMID: 22958860 Free PMC article.
-
Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome.Mol Endocrinol. 2008 Jul;22(7):1535-51. doi: 10.1210/me.2007-0449. Epub 2008 Apr 3. Mol Endocrinol. 2008. PMID: 18388150 Free PMC article.
-
Complex prolactin crosstalk in breast cancer: new therapeutic implications.Mol Cell Endocrinol. 2009 Aug 13;307(1-2):1-7. doi: 10.1016/j.mce.2009.03.014. Epub 2009 Apr 1. Mol Cell Endocrinol. 2009. PMID: 19524120 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous